Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LATER trial of extended letrozole retreatment after prior adjuvant endocrine therapy
ACTRN12607000137493Phase 3Completed
- Sponsor
- Breast Cancer Trials
- Start
- May 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of letrozole in breast cancer (2 arms), sponsored by Breast Cancer Trials. Primary endpoints: New breast cancer events and All-cause mortality. Started May 2007; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12607000137493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12607000137493.